Trial Profile
Study of direct oral anticoagulants in acute pulmonary embolism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2018
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary)
- Indications Pulmonary embolism
- Focus Adverse reactions
- 18 Sep 2018 New trial record
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology